PreciGenome
PrivateCompany Overview
PreciGenome operates in Healthcare & Life Sciences and is based in San Jose, California. It was founded in 2017.
PreciGenome is a life sciences company that develops microfluidic technology, PCR systems, and lipid nanoparticle synthesis solutions for pharmaceutical and diagnostic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PreciGenome Comparables
Compare PreciGenome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inside Therapeutics | 84% | |
| Danaher | 81% | |
| Hangzhou TinkerBio Technology Co., Ltd. | 79% |
For institutional investors. Book with your work email.
PreciGenome Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2024
Grew 43% QoQ, from 7 to 10 employees.
For institutional investors. Book with your work email.
PreciGenome Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PreciGenome's valuation, stock price, and market status.
Is PreciGenome a public or private company?
PreciGenome is a private company.
What is the current stock price of PreciGenome?
PreciGenome is a private company, so its shares have no public market price. Caplight tracks PreciGenome's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PreciGenome worth (valuation)?
Valuation information for PreciGenome is not publicly available.
Can I buy PreciGenome stock?
PreciGenome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PreciGenome's last funding round?
Funding round information for PreciGenome is not publicly available.
Who are the main investors in PreciGenome?
Investor information for PreciGenome is not publicly disclosed.
Will PreciGenome IPO soon?
No public IPO plans have been announced for PreciGenome.
How can I track PreciGenome secondary market activity?
Caplight tracks bids, offers, and trades in PreciGenome's shares on secondary markets.